FierceBiotech ٢٧ مايو ٢٠٢٦ D&D sees fibrosis improvements, MASH resolution after rolling dice on GLP-1 drug
FierceBiotech ٢٧ مايو ٢٠٢٦ Insulet issues voluntary correction for Omnipod devices in leaky insulin fault
FierceBiotech ٢٧ مايو ٢٠٢٦ Apogee bags $1.3B Blackstone royalty funding deal to push eczema challenger into phase 3
FierceBiotech ٢٧ مايو ٢٠٢٦ Dexcom warns of stolen glucose monitors being sold by unauthorized dealers
FierceBiotech ٢٧ مايو ٢٠٢٦ FDA delays ruling on AstraZeneca’s breast cancer drug after negative adcomm vote
FierceBiotech ٢٦ مايو ٢٠٢٦ As calls for COINS Act expansion grow, will new rules sweep up China biotech licensing?
FierceBiotech ٢٦ مايو ٢٠٢٦ Makary’s FDA reforms ‘continue to move forward’ despite leadership turmoil
FierceBiotech ٢٦ مايو ٢٠٢٦ Kura posts Krazati combo data on drug designed to unleash KRAS inhibitors’ potential
FierceBiotech ٢٦ مايو ٢٠٢٦ Lilly inks deals to buy 3 vaccine developers for up to $3.8B as M&A spree continues
FierceBiotech ٢٦ مايو ٢٠٢٦ Facing looming Xtandi patent cliff, Astellas pins hopes on more deals while still cutting costs
FierceBiotech ٢٥ مايو ٢٠٢٦ Lilly preps for ph. 2 launch after Verve gene editor cuts cholesterol on par with PCSK9 inhibitors
FierceBiotech ٢٢ مايو ٢٠٢٦ Has Novartis’ T-Charge been overtaken by in vivo CAR-Ts? Execs argue there’s room for both
FierceBiotech ٢٢ مايو ٢٠٢٦ OSE turns up the heat on ovarian cancer with phase 2, Keytruda-supported win